Amicus presents positive data on Pompe drug, but could wait years for approval By MATTHEW HERPER @matthewherper FEBRUARY 5, 2019

Amicus has positive data on Pompe drug but may wait years for approval

Amicus presents positive data on Pompe drug, but could wait years for approval

By MATTHEW HERPER @matthewherper

FEBRUARY 5, 2019

More reads

• Ketamine could be the key to reversing America’s rising suicide rate. (Bloomberg Businessweek)
• Amicus presents positive data on Pompe drug, but could wait years for approval. (STAT Plus)
• Cancer-vaccine maker BioNTech considering an IPO in U.S. (Bloomberg)
• Property tycoon Vincent Tchenguiz turns to biotech investing. (Financial Times)